ZA921799B - Methods for selecting antibody reagents;anti-idiotype antibodies and aids vaccine formulations - Google Patents

Methods for selecting antibody reagents;anti-idiotype antibodies and aids vaccine formulations

Info

Publication number
ZA921799B
ZA921799B ZA921799A ZA921799A ZA921799B ZA 921799 B ZA921799 B ZA 921799B ZA 921799 A ZA921799 A ZA 921799A ZA 921799 A ZA921799 A ZA 921799A ZA 921799 B ZA921799 B ZA 921799B
Authority
ZA
South Africa
Prior art keywords
methods
vaccine formulations
idiotype antibodies
antibody reagents
aids vaccine
Prior art date
Application number
ZA921799A
Inventor
Chang-Yuil Kang
Kang Chang-Yuil
Original Assignee
Idec Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idec Pharma Corp filed Critical Idec Pharma Corp
Publication of ZA921799B publication Critical patent/ZA921799B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4216—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig
    • C07K16/4225—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig against anti-HIV Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
ZA921799A 1991-03-11 1992-03-11 Methods for selecting antibody reagents;anti-idiotype antibodies and aids vaccine formulations ZA921799B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66826691A 1991-03-11 1991-03-11

Publications (1)

Publication Number Publication Date
ZA921799B true ZA921799B (en) 1992-11-25

Family

ID=24681650

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA921799A ZA921799B (en) 1991-03-11 1992-03-11 Methods for selecting antibody reagents;anti-idiotype antibodies and aids vaccine formulations

Country Status (3)

Country Link
AU (1) AU1538392A (en)
WO (1) WO1992015885A1 (en)
ZA (1) ZA921799B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6193982B1 (en) 1995-04-27 2001-02-27 The United States Of America As Represented By The Department Of Health & Human Services Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120
US7048935B2 (en) 1995-04-27 2006-05-23 The United States Of America As Represented By The Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US6428790B1 (en) 1995-04-27 2002-08-06 The United States Of America As Represented By The Secretary Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US5843882A (en) 1995-04-27 1998-12-01 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides
US6780847B2 (en) 1995-04-27 2004-08-24 The United States Of America As Represented By The Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
US6987096B1 (en) 1995-04-27 2006-01-17 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof
EP1456382B1 (en) 2001-03-22 2007-08-08 The United States of America, represented by the Secretary, Department of Health and Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
AT410637B (en) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie USE OF POLYCLONAL IMMUNOGLOBULINES
ITTO20070066A1 (en) 2007-01-30 2008-07-31 Pomona Biotechnologies Llc ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMOTOPI ANTIGENE GP 120 DI HIV
ITTO20080204A1 (en) 2008-03-17 2009-09-18 Pomona Biotechnologies Llc MONOCLONAL ANTIBODIES ACTIONS TO REACT WITH A PLURALITY OF SUBTIPS OF THE INFLUENTIAL VIRUS A
ITTO20080398A1 (en) 2008-05-27 2009-11-28 Pomona Biotechnologies Llc MONOCLONAL ANTIBODIES HAVING PROPERTY OF HOSUBLICTIC CROSS-NEUTRALIZATION FOR INFLUENTIAL VIRUSES OF SUBTIPLE TYPE H1
ITTO20080964A1 (en) 2008-12-22 2010-06-23 Natimab Therapeutics S R L ANTI-HCV MONOCLONAL ANTIBODY AS A MEDICATION FOR THERAPEUTIC TREATMENT AND THE PREVENTION OF HCV INFECTIONS
IT1395961B1 (en) 2009-06-01 2012-11-02 Pomona Biotechnologies Llc MONOCLONAL ANTIBODIES AS A MEDICATION FOR THERAPEUTIC AND / OR PROFILACTIC TREATMENT OF INFLUENCIAL VIRUS INFECTIONS (H1N1) OF SWINE ORIGIN (S-OIV)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4908203A (en) * 1987-09-09 1990-03-13 Johnson & Johnson Method for inducing HIV neutralizing antibodies using an internal image idiotope

Also Published As

Publication number Publication date
AU1538392A (en) 1992-10-06
WO1992015885A1 (en) 1992-09-17

Similar Documents

Publication Publication Date Title
EP0809806A4 (en) Monoclonal antibodies for human osteogenic cell surface antigens
EP0870826A4 (en) Novel protein and monoclonal antibody specific thereto
HU9601908D0 (en) T cell antigen receptor v region proteins and methods of preparation thereof
ZA921799B (en) Methods for selecting antibody reagents;anti-idiotype antibodies and aids vaccine formulations
IL101201A0 (en) Methods for selecting antibody reagents,anti-idiotype antibodies and aids vaccine formulations
EP0580859A4 (en) Anti-eda monoclonal antibody
IL100869A0 (en) Monoclonal ige receptor antibodies
AU1423892A (en) Monoclonal antibodies directed towards mycobacterial antigens
EP0506523A3 (en) Monoclonal antibodies
AU4274293A (en) Human monoclonal antibodies against cytomegalovirus and method for preparation thereof
AU3923293A (en) Human monoclonal antibodies and methods for human monoclonal antibody production
EP0888126A4 (en) Anti-idiotypic antibody vaccines
ZA958229B (en) Composition containing tumor rejection antigen prcursors or tumor rejection antigens and an adjuvant and/or growth factor
IL85811A0 (en) Assay for detecting hepatitis antigens and aids antibodies
HUP9601392A3 (en) Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor
EP0485749A3 (en) Chemical modification of antibodies for creating of immunoconjugates
IL78148A0 (en) Assay for antigens and antibodies and methods and device for carrying out thereof
AU2170692A (en) Me20: monoclonal antibodies and antigen for human melanoma
EP0485476A4 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
AU5217890A (en) Monoclonal antibodies in vaccine formulations
AU4910893A (en) Method for the simultaneous determination of antigens and antibodies
GB8927389D0 (en) Monoclonal antibodies
AU5873094A (en) Multivalent ab1 antibodies as vaccines
EP0547631A3 (en) Antibody expression vector and antibodies produced thereby
ZA945696B (en) Novel Eimeria antibodies and antigens and methods of using the same